EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
FRA:EWL - US28176E1082 - Common Stock
70.2 EUR
+0.07 (+0.1%)
Taking everything into account, EWL scores 7 out of 10 in our fundamental rating. EWL was compared to 57 industry peers in the Health Care Equipment & Supplies industry. EWL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EWL is quite expensive at the moment. It does show a decent growth rate. With these ratings, EWL could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year EWL was profitable.
EWL had a positive operating cash flow in the past year.
EWL had positive earnings in each of the past 5 years.
EWL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
EWL has a Return On Assets of 30.75%. This is amongst the best in the industry. EWL outperforms 100.00% of its industry peers.
EWL's Return On Equity of 39.33% is amongst the best of the industry. EWL outperforms 98.25% of its industry peers.
The Return On Invested Capital of EWL (9.25%) is better than 77.19% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EWL is above the industry average of 8.81%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.75% | ||
| ROE | 39.33% | ||
| ROIC | 9.25% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
EWL's Profit Margin of 72.96% is amongst the best of the industry. EWL outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of EWL has grown nicely.
EWL has a Operating Margin of 27.94%. This is amongst the best in the industry. EWL outperforms 96.49% of its industry peers.
In the last couple of years the Operating Margin of EWL has remained more or less at the same level.
Looking at the Gross Margin, with a value of 78.87%, EWL belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
EWL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.94% | ||
| PM (TTM) | 72.96% | ||
| GM | 78.87% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EWL is still creating some value.
The number of shares outstanding for EWL has been reduced compared to 1 year ago.
The number of shares outstanding for EWL has been reduced compared to 5 years ago.
The debt/assets ratio for EWL has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 12.49 indicates that EWL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.49, EWL belongs to the top of the industry, outperforming 98.25% of the companies in the same industry.
The Debt to FCF ratio of EWL is 1.03, which is an excellent value as it means it would take EWL, only 1.03 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.03, EWL belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
EWL has a better Debt to Equity ratio (0.06) than 91.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.03 | ||
| Altman-Z | 12.49 |
ROIC/WACC1.05
WACC8.78%
2.3 Liquidity
EWL has a Current Ratio of 4.68. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
EWL has a better Current ratio (4.68) than 94.74% of its industry peers.
A Quick Ratio of 3.87 indicates that EWL has no problem at all paying its short term obligations.
The Quick ratio of EWL (3.87) is better than 96.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.87 |
3. Growth
3.1 Past
The earnings per share for EWL have decreased by -0.77% in the last year.
Measured over the past 5 years, EWL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
The Revenue has decreased by -1.09% in the past year.
The Revenue has been growing slightly by 4.58% on average over the past years.
EPS 1Y (TTM)-0.77%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-4.29%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-6.13%
3.2 Future
Based on estimates for the next years, EWL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.33% on average per year.
Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 8.44% on average per year.
EPS Next Y-1.88%
EPS Next 2Y4.69%
EPS Next 3Y7.22%
EPS Next 5Y9.33%
Revenue Next Year3.67%
Revenue Next 2Y6.67%
Revenue Next 3Y7.85%
Revenue Next 5Y8.44%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 31.76, which means the current valuation is very expensive for EWL.
Compared to the rest of the industry, the Price/Earnings ratio of EWL indicates a somewhat cheap valuation: EWL is cheaper than 61.40% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.90, EWL is valued at the same level.
EWL is valuated quite expensively with a Price/Forward Earnings ratio of 28.47.
EWL's Price/Forward Earnings ratio is in line with the industry average.
EWL is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.76 | ||
| Fwd PE | 28.47 |
4.2 Price Multiples
EWL's Enterprise Value to EBITDA ratio is in line with the industry average.
EWL's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 83.06 | ||
| EV/EBITDA | 25.14 |
4.3 Compensation for Growth
The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.45
EPS Next 2Y4.69%
EPS Next 3Y7.22%
5. Dividend
5.1 Amount
No dividends for EWL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EWL (9/2/2025, 7:00:00 PM)
70.2
+0.07 (+0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.93%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap41.21B
Analysts76.28
Price Target76.26 (8.63%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.25%
Min EPS beat(2)4.11%
Max EPS beat(2)4.4%
EPS beat(4)4
Avg EPS beat(4)3.37%
Min EPS beat(4)1.57%
Max EPS beat(4)4.4%
EPS beat(8)4
Avg EPS beat(8)0.66%
EPS beat(12)5
Avg EPS beat(12)0.01%
EPS beat(16)6
Avg EPS beat(16)-0.9%
Revenue beat(2)0
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-0.12%
Revenue beat(4)0
Avg Revenue beat(4)-4.22%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-0.12%
Revenue beat(8)0
Avg Revenue beat(8)-3.15%
Revenue beat(12)1
Avg Revenue beat(12)-2.51%
Revenue beat(16)1
Avg Revenue beat(16)-2.76%
PT rev (1m)5%
PT rev (3m)5.09%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)-3.42%
EPS NY rev (1m)0.56%
EPS NY rev (3m)0.69%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)3.08%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.76 | ||
| Fwd PE | 28.47 | ||
| P/S | 8.44 | ||
| P/FCF | 83.06 | ||
| P/OCF | 60.38 | ||
| P/B | 4.55 | ||
| P/tB | 6.32 | ||
| EV/EBITDA | 25.14 |
EPS(TTM)2.21
EY3.15%
EPS(NY)2.47
Fwd EY3.51%
FCF(TTM)0.85
FCFY1.2%
OCF(TTM)1.16
OCFY1.66%
SpS8.31
BVpS15.42
TBVpS11.11
PEG (NY)N/A
PEG (5Y)4.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.75% | ||
| ROE | 39.33% | ||
| ROCE | 13.14% | ||
| ROIC | 9.25% | ||
| ROICexc | 13.94% | ||
| ROICexgc | 22.05% | ||
| OM | 27.94% | ||
| PM (TTM) | 72.96% | ||
| GM | 78.87% | ||
| FCFM | 10.17% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexcg growth 3Y-5.47%
ROICexcg growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score7
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.03 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 142.95% | ||
| Cap/Sales | 3.82% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 45.68% | ||
| Profit Quality | 13.93% | ||
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.87 | ||
| Altman-Z | 12.49 |
F-Score7
WACC8.78%
ROIC/WACC1.05
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.77%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-4.29%
EPS Next Y-1.88%
EPS Next 2Y4.69%
EPS Next 3Y7.22%
EPS Next 5Y9.33%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-6.13%
Revenue Next Year3.67%
Revenue Next 2Y6.67%
Revenue Next 3Y7.85%
Revenue Next 5Y8.44%
EBIT growth 1Y0.21%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.05%
EBIT Next 3Y11.53%
EBIT Next 5Y12.05%
FCF growth 1Y-15.26%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-15.47%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%